312 related articles for article (PubMed ID: 8872325)
21. Proliferative activity is a significant prognostic factor in male breast carcinoma.
Pich A; Margaria E; Chiusa L
Am J Pathol; 1994 Aug; 145(2):481-9. PubMed ID: 7519830
[TBL] [Abstract][Full Text] [Related]
22. Prognostic factors in urachal adenocarcinoma. A study in 41 specimens of DNA status, proliferating cell-nuclear antigen immunostaining, and argyrophilic nucleolar-organizer region counts.
Nakanishi K; Kawai T; Suzuki M; Torikata C
Hum Pathol; 1996 Mar; 27(3):240-7. PubMed ID: 8600037
[TBL] [Abstract][Full Text] [Related]
23. Standardized in situ AgNOR analysis in breast pathology: diagnostic and cell kinetic implications.
Bànkfalvi A; Ofner D; Schmid KW; Schmitz KJ; Breukelmann D; Krech R; Böcker W
Pathol Res Pract; 1999; 195(4):219-29. PubMed ID: 10337659
[TBL] [Abstract][Full Text] [Related]
24. [Clinical significance of argyrophilic nucleolar organizer regions (AgNOR) and microvessel quantitation by staining for factor VIII-related antigen as prognostic indicators in stage I breast cancer].
Ogawa Y; Chung YS; Nakata B; Takatsuka S; Maeda K; Sawada T; Kato Y; Yoshikawa K; Sowa M
Gan To Kagaku Ryoho; 1995 Apr; 22 Suppl 1():66-70. PubMed ID: 7747994
[TBL] [Abstract][Full Text] [Related]
25. Argyrophilic nucleolar organizer region (AgNOR) area per nucleus as a prognostic factor in breast cancer.
Nakayama K; Abe R
J Surg Oncol; 1995 Nov; 60(3):160-7. PubMed ID: 7475065
[TBL] [Abstract][Full Text] [Related]
26. Evaluation of the argyrophilic nucleolar organizer region, nuclear DNA content and mean nuclear area in transitional cell carcinoma of bladder using a quantitative image analyzer.
Shiina H; Urakami S; Shirakawa H; Shigeno K; Himeno Y; Mizutani M; Igawa M; Ishibe T
Eur Urol; 1996; 29(1):99-105. PubMed ID: 8821699
[TBL] [Abstract][Full Text] [Related]
27. AgNORs in breast tumours.
Ceccarelli C; Trerè D; Santini D; Taffurelli M; Chieco P; Derenzini M
Micron; 2000 Apr; 31(2):143-9. PubMed ID: 10588060
[TBL] [Abstract][Full Text] [Related]
28. Prognostic value of argyrophilic nucleolar organizer region (AgNOR) staining in feline intestinal lymphoma.
Rassnick KM; Mauldin GN; Moroff SD; Mauldin GE; McEntee MC; Mooney SC
J Vet Intern Med; 1999; 13(3):187-90. PubMed ID: 10357106
[TBL] [Abstract][Full Text] [Related]
29. Argyrophilic nucleolar organizer region counts and prognosis in multiple myeloma.
Pich A; Marmont F; Chiusa L; Cappello N; Resegotti L; Navone R
Br J Haematol; 1992 Dec; 82(4):681-8. PubMed ID: 1482655
[TBL] [Abstract][Full Text] [Related]
30. Argyrophilic proteins of nucleolar organizer regions (AgNORs) in fallopian tube carcinomas.
Rabczyńiski JK; Kochman AT; Karmowski A; Woźniak ZM; Bronowicz A; Terpiłowski L
Clin Exp Obstet Gynecol; 2000; 27(2):125-8. PubMed ID: 10968353
[TBL] [Abstract][Full Text] [Related]
31. Cell cycle-dependent AgNOR analysis in invasive breast cancer.
Krüger S; Stahlhut M; Müller H
Anal Quant Cytol Histol; 2000 Oct; 22(5):358-63. PubMed ID: 11064811
[TBL] [Abstract][Full Text] [Related]
32. [Nucleolus organizer regions in pathomorphologic tumor diagnosis].
Rüschoff J
Veroff Pathol; 1992; 139():1-144. PubMed ID: 1413987
[TBL] [Abstract][Full Text] [Related]
33. Modified silver staining of nucleolar organizer regions to improve the accuracy of image analysis.
Orrea SC; Tomasi VH; Schwint AE; Itoiz ME
Biotech Histochem; 2001 Mar; 76(2):67-73. PubMed ID: 11440307
[TBL] [Abstract][Full Text] [Related]
34. Argyrophilic nucleolar organizer regions in breast cancer: prognostic significance.
Kolár Z; Zábranský T; Mattler K; Zábranský E
Cesk Patol; 1992 Sep; 28(4):193-200. PubMed ID: 1335841
[TBL] [Abstract][Full Text] [Related]
35. Argyrophilic nucleolar organizer region (AgNOR) counting in astrocytic gliomas: prognostic value.
Ferreres JC; Figols J; Val-Bernal JF; Cardesa A; Cruz Sánchez FF
Histol Histopathol; 1996 Jan; 11(1):35-9. PubMed ID: 8720446
[TBL] [Abstract][Full Text] [Related]
36. Nucleoli and AgNOR proteins in 32 cases of primary breast carcinoma. Spatial pattern of interactions between 50 clinical and histometric criteria.
Lesty C; Chleq C; Contesso G; Jacquillat C
Anal Quant Cytol Histol; 1992 Jun; 14(3):175-86. PubMed ID: 1418267
[TBL] [Abstract][Full Text] [Related]
37. Interphase AgNOR quantity and DNA content in endometrial adenocarcinoma.
Trerè D; Melchiorri C; Chieco P; Marabini A; Derenzini M
Gynecol Oncol; 1994 May; 53(2):202-7. PubMed ID: 8188080
[TBL] [Abstract][Full Text] [Related]
38. Significance of silver-stained nucleolar organizer regions in early diagnosis and prognosis of oral squamous cell carcinoma: a multivariate analysis.
Pillai KR; Sujathan K; Madhavan J; Abraham EK
In Vivo; 2005; 19(4):807-12. PubMed ID: 16001464
[TBL] [Abstract][Full Text] [Related]
39. AgNOR counts have no prognostic value in breast cancer.
Toikkanen S; Joensuu H
J Pathol; 1993 Feb; 169(2):251-4. PubMed ID: 8445490
[TBL] [Abstract][Full Text] [Related]
40. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status.
Derenzini M; Ceccarelli C; Santini D; Taffurelli M; Treré D
J Clin Pathol; 2004 Jul; 57(7):755-61. PubMed ID: 15220371
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
